Wednesday, January 12, 2022
If you’re lucky enough to find an at-home COVID test, private insurers will soon be required to pay for it. Medicare decides to only cover Biogen’s controversial Alzheimer’s drug for a subset of patients in clinical trials. And Omicron is...
The Gist Healthcare Podcast · Gist Healthcare Daily
January 12, 20226m 26s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
If you’re lucky enough to find an at-home COVID test, private insurers will soon be required to pay for it. Medicare decides to only cover Biogen’s controversial Alzheimer’s drug for a subset of patients in clinical trials. And Omicron is forcing millions to call out sick.
Hosted on Acast. See acast.com/privacy for more information.